Richard Close
Stock Analyst at Canaccord Genuity
(1.22)
# 3,648
Out of 5,170 analysts
151
Total ratings
30.89%
Success rate
-12.82%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Buy | $5 → $2 | $1.22 | +64.61% | 10 | Mar 13, 2026 | |
| PGNY Progyny | Maintains: Hold | $26 → $19 | $18.18 | +4.51% | 10 | Mar 11, 2026 | |
| TALK Talkspace | Downgrades: Hold | n/a | $5.13 | - | 3 | Mar 9, 2026 | |
| OMDA Omada Health | Maintains: Buy | $28 → $22 | $13.93 | +57.93% | 3 | Mar 6, 2026 | |
| PRVA Privia Health Group | Maintains: Buy | $34 → $35 | $21.77 | +60.77% | 10 | Feb 27, 2026 | |
| TDOC Teladoc Health | Maintains: Buy | $12 → $10 | $5.52 | +81.16% | 17 | Feb 26, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $6.46 | +54.80% | 2 | Feb 26, 2026 | |
| WAY Waystar Holding | Maintains: Buy | $54 → $30 | $24.78 | +21.07% | 7 | Feb 18, 2026 | |
| HNGE Hinge Health | Maintains: Buy | $65 → $53 | $44.51 | +19.07% | 4 | Feb 11, 2026 | |
| DOCS Doximity | Upgrades: Buy | $48 → $34 | $24.80 | +37.10% | 14 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.7 | $1.89 | +95.77% | 6 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 | $20.56 | +36.19% | 9 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $33 | $11.77 | +180.37% | 12 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $9 | $2.74 | +228.47% | 13 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1.6 → $1.5 | $0.66 | +126.01% | 8 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $10.08 | +48.81% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $127.41 | -5.03% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $29.13 | -17.61% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $68.73 | +38.22% | 9 | Apr 22, 2021 |
Health Catalyst
Mar 13, 2026
Maintains: Buy
Price Target: $5 → $2
Current: $1.22
Upside: +64.61%
Progyny
Mar 11, 2026
Maintains: Hold
Price Target: $26 → $19
Current: $18.18
Upside: +4.51%
Talkspace
Mar 9, 2026
Downgrades: Hold
Price Target: n/a
Current: $5.13
Upside: -
Omada Health
Mar 6, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $13.93
Upside: +57.93%
Privia Health Group
Feb 27, 2026
Maintains: Buy
Price Target: $34 → $35
Current: $21.77
Upside: +60.77%
Teladoc Health
Feb 26, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $5.52
Upside: +81.16%
LifeStance Health Group
Feb 26, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $6.46
Upside: +54.80%
Waystar Holding
Feb 18, 2026
Maintains: Buy
Price Target: $54 → $30
Current: $24.78
Upside: +21.07%
Hinge Health
Feb 11, 2026
Maintains: Buy
Price Target: $65 → $53
Current: $44.51
Upside: +19.07%
Doximity
Feb 9, 2026
Upgrades: Buy
Price Target: $48 → $34
Current: $24.80
Upside: +37.10%
Jan 20, 2026
Maintains: Buy
Price Target: $3.7
Current: $1.89
Upside: +95.77%
Dec 17, 2025
Maintains: Hold
Price Target: $28
Current: $20.56
Upside: +36.19%
Dec 9, 2025
Maintains: Buy
Price Target: $38 → $33
Current: $11.77
Upside: +180.37%
Nov 14, 2025
Maintains: Buy
Price Target: $16 → $9
Current: $2.74
Upside: +228.47%
Nov 12, 2025
Maintains: Hold
Price Target: $1.6 → $1.5
Current: $0.66
Upside: +126.01%
Nov 6, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $10.08
Upside: +48.81%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $127.41
Upside: -5.03%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $29.13
Upside: -17.61%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $68.73
Upside: +38.22%